Skip to search formSkip to main contentSkip to account menu

Imrecoxib

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dear Editor, Pei et al. report the comparative pharmacokinetics of imrecoxib, a cyclooxygenase (COX) inhibitor [1], in healthy… 
2020
2020
We appreciate the thoughtful comments fromDr. Srinivas. We are grateful that they have given our paper such careful attention and… 
2018
2018
A sensitive LC/MS/MS method was developed and validated for the identification and quantification Imrecoxib, its hydroxyl… 
2018
2018
A sensitive LC/MS/MS method was developed and validated for the identification and quantification Imrecoxib, its hydroxyl… 
2013
2013
OBJECTIVE:To establish a method for the content determination of Imrecoxib tablets. METHODS:HPLC method was adopted. The… 
2012
2012
Pharmacophore-based drug design is one of the important approaches for follow-on drug discovery.A pharmacophore model was first… 
2011
2011
OBJECTIVE To evaluate the efficacy and safety of imrecoxib in treatment of osteoarthritis(OA).METHODS A multicenter,double-blind… 
2011
2011
OBJECTIVE To evaluate the safety and tolerability of single-dose and multi-dose oral of imrecoxib in Chinese healthy volunteers… 
2006
2006
The metabolism and excretion of imrecoxib, a novel and moderately selective cyclooxygenase-II inhibitor, were investigated in rat… 
2006
2006
AbstractAim:Imrecoxib is a novel and moderately selective COX-2 inhibitor. The aim of the present in vitro investigation was to…